top of page

The world’s first and only integrated urology platform

A vertically integrated medical device company with leading market position in urological stone treatment, Advanced MedTech has a diverse commercial portfolio of paradigm-shifting innovations that have the potential to transform and improve the lives of patients suffering from urological conditions.


We are the only, fully integrated medical device company to offer a comprehensive suite of healthcare solutions, from capital equipment and consumables, to clinical urology services for stone treatment. We are also home to the largest urology community in the world, and have unparalleled understanding of the kidney stone patient journey.

Capital Equipment


Clinical Urology Services


A pioneer in ESWL and Laser Lithotripsy, Dornier MedTech leads the ESWL Devices and Holmium Laser Systems / Fibre markets in the U.S. and Europe


people will have a kidney stone at some point in their lifetime.


Stone Disease is the urologic condition with the highest healthcare burden each year.



of patients experience two or more recurrences of stone disease.



Next generation of the world’s best selling lithotriptor

The Dornier Delta   III is the next generation of lithotriptor that offers powerful imaging for improved stone visualisation, maximised energy to treat more stones in more patients, enhanced efficiency for time saving features to serve more patients. Dornier Delta   III supports urologists in relieving kidney stones in patients and improving the bottom line of their business.




Leader in Laser Stone Management

Dornier Medilas H Solvo easily integrates into any operating room workflow for the destruction of stones as well as soft tissue interventions in endourology. The Solvo product portfolio includes 30W and 35W holmium lasers which enable urologists to manage a variety of stones in lithotripsy and deliver stone free outcomes. Equipped with special advanced modes, usability and efficiency is optimised. The Medilas H Solvo offers unparalleled flexibility and versatility as compared to the other devices in the market.

The only treatment to improve the health of erectile tissue, fulfilling unmet market demand for an effective, non-invasive and lasting solution.

men worldwide are 

projected to suffer from

Erectile Dysfunction by 2025



Erectile Dysfunction 

market size

men newly diagnosed with Erectile Dysfunction are younger than 40




Low Intensity Shockwave Treatment for Various Urological Indications

The Aries   II is the technology leader in low intensity extracorporeal shockwave treatment (Li-ESWT). The device has proved clinical results in being able to treat Erectile Dysfunction through angiogenesis (formation of new blood vessels), and is the only treatment to improve the health of erectile tissue – fulfilling demand for an effective, non-invasive and lasting solution.


Aside from Erectile Dysfunction, the Aries   II has future clinical trials in the pipeline for other urological applications, such as Chronic Pelvic Pain Syndrome and  Peyronie’s Disease.



bottom of page